Literature DB >> 5328006

Clinical evaluation of ethambutol in pulmonary tuberculosis.

I Donomae, K Yamamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5328006     DOI： 10.1111/j.1749-6632.1966.tb45528.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  17 in total

1.  A comparison of rifampicin, ethambutol or PAS in short-term monotherapy in pretreated cavitary pulmonary tuberculosis.

Authors: 
Journal:  Pneumonologie       Date:  1975-12-12

Review 2.  An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future.

Authors:  Jotam Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

Review 3.  Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action.

Authors:  Katherine A Sacksteder; Marina Protopopova; Clifton E Barry; Koen Andries; Carol A Nacy
Journal:  Future Microbiol       Date:  2012-07       Impact factor: 3.165

Review 4.  Pulmonary tuberculosis: evolution of modern therapy.

Authors:  M B Rosenblatt
Journal:  Bull N Y Acad Med       Date:  1973-03

5.  [Difficulties in ethambutol dosage].

Authors:  I Schütz
Journal:  Pneumonologie       Date:  1971

6.  Modern management of tuberculosis.

Authors:  R C Young; A C Lindo; R L Hackney
Journal:  J Natl Med Assoc       Date:  1969-05       Impact factor: 1.798

7.  Tuberculosis: who should prescribe?

Authors:  A G Wardman; S E Williams; P G Curzon; R L Page; N J Cooke
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-20

8.  [Results of daily-oral therapy with ethambutol and isoniazid in tuberculosis (author's transl)].

Authors:  H K Schwabe; A Heymer; A Wahlen; M Stollenwerk
Journal:  Pneumonologie       Date:  1973-09-28

9.  Myelopathy during treatment for pulmonary tuberculosis.

Authors:  A C Reid; I Bone
Journal:  Postgrad Med J       Date:  1980-07       Impact factor: 2.401

Review 10.  Neurological manifestations and toxicities of the antituberculosis drugs. A review.

Authors:  M R Holdiness
Journal:  Med Toxicol       Date:  1987 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.